Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Cholecystokinin - Exploring Peptides

Cholecystokinin (CCK) is a peptide hormone primarily produced in the small intestine and plays a key role in digestion and appetite regulation. It is secreted by I-cells in the duodenum and jejunum in response to food, particularly fats and proteins. CCK has s

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Cholecystokinin (CCK) is a peptide hormone primarily produced in the small intestine and plays a key role in digestion and appetite regulation. It is secreted by I-cells in the duodenum and jejunum in response to food, particularly fats and proteins. CCK has several physiological effects, including stimulating the release of digestive enzymes from the pancreas, promoting the contraction of the gallbladder to release bile, and regulating satiety signals in the brain. Its dual role in digestive processes and appetite control makes it a critical hormone for maintaining gastrointestinal health and energy balance.

Category

Peptide hormone

Sequence

The most common form of CCK in humans is CCK-33, which has 33 amino acids. Other forms, such as CCK-8, CCK-22, and CCK-58, are also present

Molecular Weight

It varies based on the specific form, with CCK-8 having a molecular weight of approximately 1,144.28 g/mol

Molecular Formula

Like Molecular weight, it varies based on the form. For CCK-8, the formula is C49H62N10O16S3

Most Common Uses:

Pancreatic Stimulation: CCK stimulates the pancreas to release digestive enzymes, including lipases, proteases, and amylases, which break down fats, proteins, and carbohydrates in the intestines.

Gallbladder Contraction: CCK promotes the contraction of the gallbladder, releasing bile into the small intestine. Bile is essential for the emulsification and absorption of dietary fats.

Regulation of Appetite: CCK acts on the brain, particularly the hypothalamus, to reduce appetite and promote feelings of fullness after eating. This satiety signal is crucial for preventing overeating and maintaining energy balance.

Motility in the Digestive Tract: CCK helps slow food’s emptying from the stomach into the small intestine, allowing for more efficient digestion and nutrient absorption. This delayed gastric emptying contributes to feelings of fullness and supports proper digestive timing.

Appetite Regulation Studies: CCK is widely studied in relation to its role in appetite control and potential treatments for obesity. Its ability to influence satiety and food intake makes it a target for therapeutic research.

Gastrointestinal Studies: Research into CCK’s effects on the pancreas, gallbladder, and intestinal motility is ongoing, particularly in understanding digestive disorders such as pancreatitis, gallstones, and malabsorption syndromes.

Warnings and Cautions:

Oversecretion of CCK: Excess CCK production can lead to gastrointestinal issues such as pancreatitis, gallbladder disease, and bloating. This is often seen in conditions where the hormone is overstimulated, such as gallstones or certain tumors.

Potential Effects on Appetite: While CCK reduces appetite, excessive stimulation or supplementation aimed at appetite suppression could lead to inadequate nutrient intake or gastrointestinal discomfort.

Dosages:

Diagnostic Use: CCK is used diagnostically in CCK-cholescintigraphy, a test that assesses gallbladder function. In this test, synthetic CCK is administered to trigger gallbladder contraction, allowing doctors to measure how well the gallbladder releases bile.

Research and Experimental Use: In research settings, CCK is administered to study its effects on digestion, appetite regulation, and its role in disorders like pancreatitis. The dosing varies widely based on the form of CCK used and the experimental design.

Mechanism of Action:

Cholecystokinin exerts its effects by binding to CCK receptors, primarily CCK-A receptors (found in the digestive system) and CCK-B receptors (found in the brain). In the digestive system, CCK-A receptor activation stimulates the pancreas to release digestive enzymes and causes the gallbladder to contract, releasing bile. In the brain, CCK-B receptor activation is involved in regulating satiety, reducing food intake by sending signals of fullness to the hypothalamus.

Benefits:

Improved Fat Digestion: CCK promotes bile release and stimulates pancreatic enzyme secretion, helping to break down and absorb dietary fats efficiently.

Appetite Regulation: CCK’s role in sending satiety signals to the brain helps control food intake, making it crucial for maintaining energy balance and preventing overeating.

Supports Digestive Efficiency: By slowing gastric emptying, CCK ensures that food is digested properly in the small intestine, allowing for better nutrient absorption and preventing digestive discomfort.

Potential in Weight Management: Given its appetite-suppressing effects, CCK is a focus of research in the development of treatments for obesity and metabolic disorders.

Closing:

Cholecystokinin (CCK) is a key hormone involved in both digestion and appetite regulation. Its ability to stimulate the release of digestive enzymes and bile, along with its role in sending satiety signals to the brain, highlights its importance in maintaining both gastrointestinal health and energy balance. While CCK has therapeutic potential in treating digestive disorders and managing obesity, its dysregulation can contribute to conditions like gallstones, pancreatitis, and appetite-related issues. As research continues, CCK’s role in both digestive and endocrine systems remains a crucial area of study.

Sourcing

USA

LIMITLESS LIFE NOOTROPICS aka Biotech

Use Discount Code: EP20

SCANTIFIX

Use Discount Code: Exploringpeptides

Canada

BIOSLAB

Use Discount Code: EP10

Europe

DNLABResearch

Use Discount Code: EP15

Australia

LVLUPHEALTH

Related articles

SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332

Adalank vs Selank: Differences, Benefits and Effects

Adamax vs Semax: Comparison, Benefits, and Effects

Common Mistakes When Reconstituting Peptides

Peptides Vs Proteins: What’s The Difference?

What Are Peptides and How Do They Work?

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Case Studies and Success Stories

Real-life success stories of peptides for mental health illuminate the potential benefits of peptide therapy for mental health. On various online platforms, such as message boards and Reddit, individuals have shared their experiences, providing anecdotal evidence of positive outcomes. Some users have experienced a noticeable improvement in their mood and a reduction in anxiety after incorporating peptide therapy into their routine.11 Others have highlighted the impact of peptide therapy on cognitive function and observed enhanced focus and better memory recall, leading to improved productivity in their work and personal life.12 These users often credited these benefits to the inclusion of peptides in their mental health regimen. While these stories offer insights into the potential advantages of peptide therapy, it’s crucial to approach them with a discerning eye. Anecdotal evidence, while valuable, does not replace Scientific Research. Each individual’s response to peptide therapy can vary, and what works for one may not work the same way for another.

Source: driphydration.com ↗

Featured Articles & Research

Sermorelin Guide: Benefits, Side Effects, Dosage & More SLU-PP-915: Benefits, Research & Comparison with SLU-PP-332 Adalank vs Selank: Differences, Benefits and Effects

Source: exploring-peptides.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosages:

Migraine Treatment: Gepants and Monoclonal Antibodies: CGRP inhibitors, such as gepants (oral CGRP receptor antagonists) and CGRP monoclonal antibodies, are typically administered in doses based on the specific drug. Gepants like ubrogepant and rimegepant are taken orally, while monoclonal antibodies like erenumab, fremanezumab, and galcanezumab are administered subcutaneously on a monthly or quarterly basis, depending on the formulation. Experimental Research: Variable Dosing: In research settings, CGRP is often administered in doses that vary according to the study design and specific focus, whether it’s for understanding its role in pain transmission, vascular function, or bone health.

Source: exploring-peptides.com ↗
Potential benefits

Benefits:

Antidepressant Effects: PE-22-28 has shown potential in alleviating symptoms of depression by modulating MCH receptors, offering a targeted approach to mood regulation without the broader effects of full MCH activity. Neuroprotection: PE-22-28 may protect neurons from oxidative damage and stress, making it a valuable tool for research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Anxiolytic Properties: PE-22-28 could help reduce anxiety and improve emotional resilience by interacting with brain pathways involved in stress response. Cognitive Support: PE-22-28’s neuroprotective and neuroactive properties may support cognitive function, including memory and learning, making it a potential candidate for cognitive enhancement.

Source: exploring-peptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →